Abstract:Non-nucleic acid targets, consisting primarily of metal ions, organic small molecules and proteins. They act as important biomolecules or cell surface markers, supplying integrated and comprehensive bio-diagnostic information for the early diagnosis and treatment of diseases. Meanwhile, the analysis of non-nucleic acid targets also offers the foundation for individualized medicine and precision therapy. Therefore, a versatile platform for non-nucleic acid targets requires development. Clustered regularly interspaced short palindromic repeats-associated protein (CRISPR/Cas) systems is driving a revolution in medical diagnostics due to high base-resolution and isothermal signal amplification. Nevertheless, the majority of CRISPR/Cas settings reported currently are targeted for nucleic acids, leaving restricted usage to non-nucleic acid targets. This is owing to the lack of suitable signal recognition transduction elements for connecting CRISPR to non-nucleic acid targets. Functional nucleic acids (FNAs), comprising aptamers and nucleic acid enzymes, are of great concern to the biological and medical professions because of their specific target recognition and catalytic properties. As appropriate, functional recognition elements, FNAs can be integrated into CRISPR/Cas systems to exploit the powerful capabilities of both. This review emphasizes the technical tricks of integrating CRISPR/Cas systems and FNAs for non-nucleic acid targeting diagnostic applications. We first offer a general overview and the current state of research in diagnostics for CRISPR/Cas and FNAs, respectively, highlighting strengths and shortcomings. A categorical summary of non-nucleic acid-targeted diagnostics is provided, with a key emphasis on fundamental insights into the versatile non-nucleic acid-targeted diagnostic toolbox. We then review emerging diagnostic strategies based on CRISPR/Cas systems and FNAs that are fast, accurate and efficient in detecting non-nucleic acid targets. Finally, we identify the challenges that remain in this emerging field and look to the future of the field, expanding to the integration of nanomaterials, development of wearable devices and point-of-care testing.

CRISPR-Microfluidics Nexus: Advancing Biomedical Applications for Understanding and Detection

Recent Progress in CRISPR-based Microfluidic Assays and Applications

Microfluidics: the propellant of CRISPR-based nucleic acid detection

CRISPR Mediated Biosensing Toward Understanding Cellular Biology and Point-of-Care Diagnosis.

Powerful CRISPR-Based Biosensing Techniques and Their Integration With Microfluidic Platforms

CRISPR/Cas Biosensing Technology: From Lab Assays to Integrated Portable Devices towards Wearables

CRISPR-Driven Biosensors: A New Frontier in Rapid and Accurate Disease Detection

Clustered Regularly Interspaced short palindromic repeats‐Based Microfluidic System in Infectious Diseases Diagnosis: Current Status, Challenges, and Perspectives

CRISPR-Cas assisted diagnostics: A broad application biosensing approach

Challenges and perspectives of CRISPR-based technology for diagnostic applications

Crispr-cas based biosensing: A fast-expanding molecular diagnostic tool

Research progress of CRISPR-based biosensors and bioassays for molecular diagnosis

CRISPR Cas system: A strategic approach in detection of nucleic acids

Advances and Challenges of Signal Readout Systems in CRISPR-based Biosensors for Point-of-care Testing of Nucleic Acid

Next-generation CRISPR/Cas-based ultrasensitive diagnostic tools: current progress and prospects

The CRISPR/Cas System: A Customizable Toolbox for Molecular Detection

CRISPR/cas systems redefine nucleic acid detection: Principles and methods

CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.

Programmable Biosensors Based on RNA-Guided CRISPR/Cas Endonuclease

CRISPR: The Frontier Technology of Next-Generation RNA Detection

Integration of CRISPR/Cas with functional nucleic acids as versatile toolbox for non-nucleic acid target diagnostics: a review